4 bodyweight stair exercises a trainer recommends for stronger legs after 60

 Your competent? doctor did get you recovered enough to do these, right? 

Oh NO, DOCTOR FAILURE AGAIN!

Just bought a 4 level condo, 7 steps to each level, will be able to practice this a lot.. Absolutely do not believe in removing steps in living quarters. Don't do steps at home, won't be able to travel to step laden places like Machu Pichu or restrooms anywhere in Europe!

4 bodyweight stair exercises a trainer recommends for stronger legs after 60

At A Glance

• Why this matters: Leg strength and power help you climb stairs, get up from a chair, stay balanced, and move more confidently as you age.
• What you can do: Use a sturdy staircase to practice step-ups, split squats, calf raises, and backward step-ups that challenge strength, power, and balance.
• The payoff: Regularly training these skills can help you maintain mobility, independence, and confidence in everyday movement as you get older.

As you get older, strong, powerful legs can make a big difference in how easily you move through everyday life. Whether you’re climbing stairs, getting out of a chair, or catching yourself when you lose your balance, your leg muscles play an important role.

While strength helps your muscles produce force, power helps you move quickly when you need to. Maintaining both as you age can make daily activities easier, improve mobility, and reduce your risk of falls.

1. Power Step-Up

Step-ups closely resemble the movement you already use to climb stairs and step onto curbs. Regular step-ups are great for training your leg muscles, but adding the power component helps train your reactivity and ability to produce force a little faster.

How to do it:

1. Stand facing the bottom stair with one hand on the railing for support if needed. 
2. Place your right foot fully on the step.
3. Press through your right foot and stand up onto the step with a quick but controlled effort.
4. Lower your left foot back to the floor slowly.
5. Complete all reps on one side before switching legs.

Aim for: 2–3 sets of 6–10 reps on each leg, resting as needed between sets.

Focus on: Pushing hard through the foot that is on the stair instead of bouncing off the foot on the floor. Your upward movement is where the speed happens, but keep your step back down controlled.

Make it easier: Use a low step, keep both hands on a secure railing, or step up at a comfortable, steady pace rather than emphasizing speed.

Make it harder: Drive up a little faster while maintaining control, or briefly bring the trailing foot beside the working foot before stepping back down.

2. Stair-Supported Split Squat

A stair-supported split squat keeps your front leg elevated while the back leg stays on the level ground behind you. Slightly elevating the front foot also lets you increase your range of motion as you dip down into the single-legged squat. Both of these elements challenge different facets of balance, strength, and mobility, all of which are important for healthy aging and everyday activities.

How to do it:

1. Place your right foot fully on the bottom stair and keep your left foot on the floor behind you.
2. Hold the railing and keep most of your weight centered between your feet.
3. Keep the pressure in your front foot and bend both knees to lower your body as far as feels comfortable.
4. Press through your front foot to return to standing.
5. Complete your reps, then switch sides.

Aim for: 2–3 sets of 6–10 reps per side.

Focus on: Pressing through the front foot and letting the back leg support you for balance. Move straight down and up instead of rocking your body forward onto the stair.

Make it easier: Use a shallow knee bend and keep both hands on a railing or other sturdy support.

Make it harder: Lower a little farther or rise slightly faster while keeping the movement smooth.

3. Supported Calf Raise

Your calf muscles help propel you forward when you walk and push you upward when you climb stairs. Calf raises strengthen that push-off while also challenging ankle control, which helps you move steadily while walking and climbing stairs. If you do them faster, they also help train your reactivity, which is essential when catching a missed step. 

How to do it:

1. Stand on the bottom stair with your heels hanging off a bit, your feet about hip-width apart, and your hands on the railing.
2. Press through the balls of your feet and big toes to lift your heels.
3. Pause briefly at the top.
4. Lower your heels slowly until they hang slightly off, then immediately press back into the calf raise. 

Aim for: 2–3 sets of 8–15 reps.

Focus on: Pressing through your big toe and rising straight up as high as you can. 

Make it easier: Keep more weight on the railing or use a smaller range of motion. You also don’t need to hang your heels off if that’s too difficult. 

Make it harder: Increase the speed by rising faster and lowering a little more slowly (2–3 seconds). 

4. Backward Step-Up

Backward step-ups are more challenging than regular step-ups because they add extra coordination and balance. Stepping backward also increases reliance on body awareness and control, which can help with everyday movements that involve changing direction or stepping behind you.

How to do it:

1. Stand with your back to the bottom stair, close enough to reach the step comfortably, and hold the railing for support.
2. Step your right foot backward and place it fully on the stair.
3. Press through your right foot to lift your body onto the step.
4. Step your left foot back down to the floor with control.
5. Complete your reps, then switch legs.

Aim for: 2–3 sets of 6–10 reps on each side.

Focus on: Shifting weight into your hip as you step backward. Keep your full foot on the step and move slowly enough to stay in control.  

Make it easier: Use a low step, keep both hands on a secure railing, and look back briefly to check your foot placement before stepping.

Make it harder: Once you can find the step confidently, use less hand support or make the upward push slightly quicker while keeping the step down controlled.

How to Add These Exercises to Your Routine

Since many of these exercises involve a power and speed component, it’s best to make sure you’re fully warmed up before doing any of them. Aim for at least a 10-15 minute warm-up beforehand, or make sure you’ve done at least a few other exercises first to get your blood flowing and your body limber.

When it comes to progressions, it’s best to master the movement first before you start making it more challenging. Once you feel comfortable with the form and complete basic versions of the exercise, you can add in new challenges. These could mean increasing how fast/explosviely you do the exercise, or simply adding more sets and reps to increase your total work volume.

You can add these leg exercises to your regular workout routine, or dedicate a day to leg power and strength. What matters most is consistency and making sure you’re doing a variety of exercises that challenge your full body with adequate strength, power, and aerobic stimulus.

Read the original article on Health

Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia

 With your risk of dementia post stroke, will your competent? doctor use this to initiate the EXACT DEMENTIA PREVENTION PROTOCOLS  that they incompetently still don't have?

1. A documented 33% dementia chance post-stroke from an Australian study?   May 2012.

2. Then this study came out and seems to have a range from 17-66%. December 2013.`    

3. A 20% chance in this research.   July 2013.

4. Dementia Risk Doubled in Patients Following Stroke September 2018 

The latest here:

Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia

Emer R. McGrath, MB, PhD https://orcid.org/0000-0002-3589-2964 emer.mcgrath@nuigalway.ie, Jayandra J. Himali, PhD, Daniel Levy, MD, Sarah C. Conner, MPH https://orcid.org/0000-0002-0929-9948, Charles DeCarli, MD, Matthew P. Pase, PhD, Toshiharu Ninomiya, MD, PhD, … Show All … , and Sudha Seshadri, MDAuthor Info & Affiliations

Journal of the American Heart Association

Volume 9, Number 19

https://doi.org/10.1161/JAHA.119.014659

Abstract

Background

GDF15 (growth differentiation factor 15) and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) may offer promise as biomarkers for cognitive outcomes, including dementia. We determined the association of these biomarkers with cognitive outcomes in a community‐based cohort.

Methods and Results

Plasma GDF15 (n=1603) and NT‐proBNP levels (n=1590) (53% women; mean age, 68.7 years) were measured in dementia‐free Framingham Offspring cohort participants at examination 7 (1998–2001). Participants were followed up for incident dementia. Secondary outcomes included Alzheimer disease dementia, magnetic resonance imaging structural brain measures, and neurocognitive performance. During a median 11.8‐year follow‐up, 131 participants developed dementia. On multivariable Cox proportional‐hazards analysis, higher circulating GDF15 was associated with an increased risk of incident all‐cause and Alzheimer disease dementia (hazard ratio [HR] per SD increment in natural log‐transformed biomarker value, 1.54 [95% CI, 1.22–1.95] and 1.37 [95% CI, 1.03–1.81], respectively), whereas higher plasma NT‐proBNP was also associated with an increased risk of all‐cause dementia (HR, 1.32; 95% CI, 1.05–1.65). Elevated GDF15 was associated with lower total brain and hippocampal volumes, greater white matter hyperintensity volume, and poorer cognitive performance. Elevated NT‐proBNP was associated with greater white matter hyperintensity volume and poorer cognitive performance. Addition of both biomarkers to a conventional risk factor model improved dementia risk classification (net reclassification improvement index, 0.25; 95% CI, 0.05–0.45).

Conclusions

Elevated plasma GDF15 and NT‐proBNP were associated with vascular brain injury on magnetic resonance imaging, poorer neurocognitive performance, and increased risk of incident dementia in individuals aged >60 years. Both biomarkers improved dementia risk classification beyond that of traditional clinical risk factors, indicating their potential value in predicting incident dementia.

Scientists found a surprising change in the brains of older adults who ate peanuts every day

 Which nut does your doctor recommend and why? Will your doctor get research going in stroke patients? NO? NOT his/her job? Better blood flow would indicate this should be IMMEDIATELY PRESCRIBED POST-STROKE!

What about walnuts? Will your incompetent? doctor chime in?

Neurologists Recommend Eating This Nut to Reduce Your Dementia Risk

Or pistachios?

The #1 nut to help lower blood pressure, according to a dietitian 

Or almonds:

Why Almonds Might Be the Healthiest Nut You Can Eat 

Or walnuts

The one nut dietitians recommend for brain, heart, and gut health

The latest here:

Scientists found a surprising change in the brains of older adults who ate peanuts every day

A bowl of peanuts sits on the counter. For 16 weeks, a group of older adults ate two handfuls a day. Then scientists looked inside their heads. You may think of insulin as a blood sugar hormone, and peanuts as just a snack. A new study links the two in the brain. The result is real, but experts say it is easy to read too much into it.

This article was created with the assistance of AI and reviewed by our editorial team for accuracy and clarity.

It Was a Small Study, but the Design Was Smart

This was a small study with a smart design. Researchers at Maastricht University Medical Center in the Netherlands tested 31 healthy adults ages 60 to 75. Each person ate 60 grams of unsalted, skin-roasted peanuts daily, about two servings, for one period. In another period, they avoided peanuts. Everyone got a turn at both, so each person served as their own comparison.

The Change Showed Up in the Brain’s Memory Zone

The change showed up in a part of the brain tied to memory. After the peanut period, a cluster in the right side of the brain responded better to insulin. It included parts of the hippocampus and other memory-related areas. The finding was regional. It does not mean every part of the brain improved. It points to one small area that scientists care about.

Insulin Does More in the Brain Than Manage Sugar

Insulin does more in the brain than manage sugar. Researchers say it also acts as a signaling molecule. It helps support nerve-cell function and processes involved in memory. That is why the way the brain responds to insulin matters to scientists who study aging. A brain that responds well may be better set up to do its job. This study checked that response.

Scientists Measured Blood Flow, Not Dementia

Scientists measured blood flow, not dementia. They gave participants insulin through the nose. Then they used MRI scans to see how blood flow changed in different parts of the brain. That makes the result a picture of how the brain responds to insulin. It is not a direct measure of anyone’s risk of dementia. The trial lists brain insulin response as a goal separate from memory testing.

An Earlier Result From the Same Trial Pointed the Same Way

An earlier result from the same trial pointed the same way. In a 2025 report in Clinical Nutrition, the group found a 3.6% rise in blood flow across the brain. Verbal memory, measured by delayed word recognition, improved 5.8%. Peter Joris of Maastricht said, “Our study found that daily peanut consumption beneficially affected insulin responsiveness in memory-related brain regions in older adults.” Those are small gains in a small group.

A Better Brain Signal Is Not a Proven Shield Against Dementia

A better brain signal is not a proven shield against dementia. The study does not show that peanuts prevent Alzheimer’s disease or dementia. A biological response can help explain a possible benefit, but it does not prove long-term protection. The trial was also small and short. In the 2025 report, participants knew when they were eating peanuts. Bigger and longer studies would be needed to say more.

The Peanut Industry Helped Pay for the Research

The peanut industry helped pay for the research. The Peanut Institute Foundation funded the study. The announcement says the funder had no role in the design, the analysis, the interpretation, or the writing of the paper. Funding does not make a result wrong. But it is a good reason to wait for more studies, ideally from other teams, before treating the finding as settled.

The Modulating Effects of Fruit and Fruit-Derived Interventions on Arterial Stiffness

 

Has your competent? doctor even measured your arterial stiffness to know what protocols to supply?

Of course you fully expect your competent? doctor and hospital to get that further research going, right? Sorry; NO plans at all. They would rather let INCOMPETENCE BE THEIR BYWORD!

The Modulating Effects of Fruit and Fruit-Derived Interventions on Arterial Stiffness

Department of Kinesiology and Health Promotion, University of Kentucky, Lexington, KY 40506, USA

Nutrients2026, 18(16), 2627;https://doi.org/10.3390/nu18162627

This article belongs to the Special Issue Nutraceuticals, Bioactive Compounds and Functional Foods: Their Role in Chronic Diseases (2nd Edition)

Abstract

Fruit and fruit-derived interventions, when provided to various populations of interest, have the potential to contribute to cardioprotective benefits. Of particular interest, arterial stiffness serves as an important prognostic marker for cardiovascular disease and events, so many intervention studies have focused on the ability of fruit and fruit-derived interventions to improve arterial stiffness, especially in the aorta. Therefore, the aim of the present narrative review was to examine the available evidence on the relationship between fruit-based interventions and arterial stiffness. Five electronic databases were searched using a structured search strategy through December 2025. Among the 68 identified clinical investigations, findings were heterogeneous, although some studies reported improvements in interventions derived from berries, grapes, citrus fruits, and watermelon. Current evidence does not support favorable effects following interventions derived from tart cherry, and many fruits lack sufficient evidence to determine whether improvements in arterial stiffness are possible. Given the wide variety of polyphenols and bioactive compounds available in fruit and fruit-based interventions, there is strong theoretical potential for these interventions to exert beneficial effects on the cardiovascular system. Nevertheless, further research is warranted to understand whether fruit-based interventions can produce demonstrable changes in arterial stiffness among varying populations, and when such changes are observed, to elucidate the mechanisms underlying these effects. Thus, additional randomized controlled trials, especially with sufficient durations and adequate sample sizes to detect structural changes in the vascular system, are needed.

Keywords:

vascular; polyphenols; antioxidative; inflammation; nitric oxide; anthocyanins; berries; hesperidin; L-citrulline

Six weeks daily ingestion of whole blueberry powder increases natural killer cell counts and reduces arterial stiffness in sedentary males and females

 Has your competent? doctor even measured your arterial stiffness to know what protocols to supply?

Six weeks daily ingestion of whole blueberry powder increases natural killer cell counts and reduces arterial stiffness in sedentary males and females

Lisa S. McAnulty ^a, , , , , , , , Steven R. McAnulty ^b

^a

Dept. of Nutrition and Health Care Management, Boone, NC, 28608

^b

Dept. of Health and Exercise Science Appalachian State University, Boone, NC, 28608

^c

Boone Dermatology, Clinic, Boone, NC, 28608

Received 1 April 2014, Revised 22 June 2014, Accepted 1 July 2014, Available online 8 July 2014.

Abstract

Evidence suggests that berries contain bioactive compounds, which reduce certain cancers and hypertension. Our hypothesis was that daily blueberry (BB) consumption would increase natural killer (NK) cells and plasma redox capacity and reduce blood pressure, augmentation index (AIx), central pulse wave velocity, and aortic systolic pressures (ASPs). Twenty-five men and postmenopausal women aged 18 to 50 years were recruited and randomized to BB (n, 13) or placebo groups (n, 12). Participants were provided with BB (equivalent to 250 g berries) or placebo powders each day for 6 weeks. Blood pressure, vascular performance testing, and blood samples were taken at baseline (presupplementation). Participants returned after 6 weeks and repeated all procedures. Presupplementation to postsupplementation comparisons for the main effects of treatment, time, and treatment-time interaction were made using a 2 (treatment) × 2 (times) repeated-measures analysis of variance for all vascular measures, redox status, and NK cell counts. Anthropometric measures were compared using t tests. Body mass, composition, and overall blood pressures were not affected in either group. Overall, AIx and ASPs were decreased in BB (treatment effect, P = .024 and P = .046, respectively). Plasma redox was not affected. Absolute NK cells were increased in BB (time, P = .001 and interaction, P = .012). Subjects (n, 9) with prehypertensive pressures (≥120/80 mm Hg, respectively) were examined as a subset using t tests and exhibited significant reductions in diastolic pressure (P = .038) from presupplementation to postsupplementation in BB. We conclude that BB ingestion for 6 weeks increases NK cells and reduces AIx, ASP, and diastolic pressures in sedentary males and females.

Keywords

Anthocyanins

;

Immunity

;

Blood pressure

;

Antioxidants

;

Hypertension

;

Neoplasms

Abbreviations

AAPH,

azobis methyl propanimidamide

;

AIx,

augmentation index

;

ANOVA,

analysis of variance

;

ASP,

aortic systolic pressure

;

BB,

blueberry

;

cPWV,

central pulse wave velocity

;

Dt,

time delay

;

eNOS,

endothelial nitric oxide synthase

;

FRAP,

ferric reducing ability of plasma

;

NK,

natural killer

;

ORAC,

oxygen radical absorptive capacity

;

PL,

placebo

;

PWV,

pulse wave velocity

Breathing “Thin Air” May Protect Against Parkinson’s

 Will this be enough to prevent your Parkinson's risk from happening? A competent? doctor would know the answer!

Parkinson’s Disease May Have Link to Stroke March 2017 

But this to consider.

Aging Brain More Vulnerable to Even Mild Oxygen Deprivation June 2025 

The latest here:

Breathing “Thin Air” May Protect Against Parkinson’s 

Summary:

A clinical study from São Paulo State University (UNESP) in Brazil demonstrates that intermittent hypoxia, controlled, alternating exposure to low-oxygen air, is safe, does not impair sleep, and improves metabolic and inflammatory biomarkers in individuals with Parkinson’s disease. Published in Parkinsonism & Related Disorders, the trial revealed that a single 39-minute session lowered stress and inflammatory markers while elevating neuroprotective adiponectin and preventing drops in brain-derived neurotrophic factor (BDNF), pointing toward an innovative complementary therapy.

Key Facts:

• Safe Hormetic Exposure: Alternating four 6-minute cycles of 10% oxygen (simulating 5,800 meters altitude) with 5-minute room-air intervals caused no adverse events, insomnia, or sleep disruptions in Parkinson’s patients or healthy controls.
• Anti-Inflammatory Shift: A single intermittent hypoxia session led to temporary reductions in cortisol and pro-inflammatory leptin, alongside a sustained 24-hour surge in anti-inflammatory adiponectin.
• Neurotrophic Preservation: While resting in normal air resulted in a standard decline in BDNF levels, intermittent hypoxia preserved circulating BDNF concentrations without increasing pro-inflammatory interleukin-6 (IL-6) or altering blood iron balance.

Source: São Paulo State University (UNESP) / FAPESP

Parkinson’s disease affects an estimated 11 million people globally, recognized clinically by the progressive loss of dopaminergic neurons in the substantia nigra that leads to classic motor signs: resting tremor, bradykinesia, postural instability, and rigidity. Yet beyond motor deficits, individuals face debilitating non-motor burdens, including metabolic disruption, systemic neuroinflammation, and persistent sleep disorders that standard dopamine-replacement medications fail to resolve.

Currently, structured physical exercise remains the only non-pharmacological strategy proven to stimulate restorative metabolic and neurotrophic changes in patients.

Now, researchers at São Paulo State University (UNESP) in Brazil, supported by the São Paulo Research Foundation (FAPESP), have uncovered a complementary physical approach: intermittent hypoxia.

Publishing in the journal Parkinsonism & Related Disorders, the team demonstrated that short, carefully metered intervals of breathing simulated high-altitude thin air activate protective cellular defenses in people with Parkinson’s disease without compromising nocturnal sleep or causing adverse reactions.

Harnessing Hormesis: The Science of Controlled Stress

Breathing thin air at high mountain summits is notoriously taxing, frequently triggering acute mountain sickness marked by nausea, headaches, and physical exhaustion. However, when delivered in brief, intermittent bursts, low oxygen operates through “hormesis”, the biological principle where mild, non-damaging cellular stress triggers robust adaptive and protective pathways.

“The initial results indicate that the technique activates protective mechanisms that can safely benefit people with Parkinson’s disease without causing adverse effects. That’s important because it allows us to conduct studies with a larger number of volunteers and with long-term protocols that evaluate the effects of repeated sessions,” said Fabio Barbieri, PhD, head of the Human Movement Research Laboratory (MOVI-LAB) and coordinator of the “Ativa Parkinson” program at UNESP Bauru.

The clinical trial evaluated 30 adult participants, 15 individuals diagnosed with Parkinson’s disease and 15 healthy age-matched controls.

During the 39-minute experimental protocol, participants wore specialized breathing masks that alternated between four 6-minute blocks of hypoxic air (10% oxygen, physiologically equivalent to an altitude of 5,800 meters) separated by three 5-minute normoxic recovery periods (21% room oxygen). On a separate visit, subjects completed a sham control session breathing standard room air throughout.

Resetting Metabolic and Neuroinflammatory Biomarkers

Blood analyses immediately following the session revealed rapid systemic recalibrations in participants with Parkinson’s:

• Hormonal Regulation: The protocol elicited significant transient drops in circulating cortisol, the primary stress hormone, as well as leptin, an adipose hormone that drives neuroinflammatory cascades when elevated.
• Adiponectin Surge: Levels of adiponectin, an endogenous metabolic factor with potent anti-inflammatory and vascular actions that is chronically suppressed in Parkinson’s, increased significantly and remained elevated for up to 24 hours.
• Preserving BDNF: While sitting inactive in normal room air led to an anticipated drop in circulating brain-derived neurotrophic factor (BDNF), a master protein governing neuronal survival and synaptic plasticity, intermittent hypoxia completely arrested this decline.

Crucially, the intervention proved safe. It did not alter systemic iron homeostasis or elevate the pro-inflammatory cytokine interleukin-6 (IL-6), eliminating concerns that hypoxia might provoke systemic inflammation.

“Maintaining stable BDNF levels is a significant finding, as that protein typically declines during periods of physical inactivity – a decline that occurred when patients underwent the control session breathing normal air. Intermittent hypoxia prevented that decline while increasing adiponectin, paving the way for further research,” said first author Murilo Henrique Faria.

Sleep Safety and Mitochondrial Sensors

A critical question was whether exposing patients to low oxygen would trigger nocturnal sleep disturbances or central sleep apneas. Objective sleep monitoring revealed zero disruptions: participants experienced no increase in nighttime awakenings or sleep onset latency.

Co-author Carlos Augusto Kalva-Filho, PhD, explains that the therapeutic benefit is driven by hypoxia-inducible factor 1-alpha (HIF-1alpha). This intracellular transcription factor acts as an oxygen sensor, coordinating mitochondrial bioenergetics and antioxidant defenses when activated by brief oxygen dips.

“It’s that precise control that generates the benefit. So, it isn’t just a matter of fleeing to the mountains,” Kalva-Filho emphasized, noting that prolonged, continuous exposure at high altitudes overburdens tissues, whereas laboratory-controlled cycles trigger cellular repair.

While a single session demonstrated safety and acute biochemical improvements, the researchers stress that intermittent hypoxia is not a cure or replacement for standard dopaminergic drugs. The team is now planning multi-week clinical trials to evaluate whether repeated sessions can produce cumulative motor, cognitive, and sleep improvements in Parkinson’s disease.

Editorial Notes:

• This article was edited by a Neuroscience News editor.
• Journal paper reviewed in full.
• Additional context added by our staff.

About this Parkinson’s disease Research:

• Media Contact: Heloisa Reinert
• Source: FAPESP
• Image Credit: Image credited to Neuroscience News
• Original Research is Open Access: Parkinsonism & Related Disorders (Oct 1, 2026). “The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson’s disease: A randomized, double-blind, crossover trial.” Authors: Murilo Henrique Faria, Carlos Augusto Kalva-Filho, Vinicius Oliveira Queiroz, Tjeerd W. Boonstra, Marcela de Oliveira, Jônatas Augusto Cursiol, Christian Schlenstedt, Fabio Santos Lira, Barbara Moura Antunes, and Fabio Augusto Barbieri.
• DOI: 10.1016/j.parkreldis.2026.108922

Three Proprioception and Vestibular Drills for Fall Prevention by SIM/60

 

Probably much better than you're getting from your doctor and therapists! I had no fall prevention or proprioception training. And nothing on how to get up after a fall.

Three Proprioception and Vestibular Drills for Fall Prevention

DRILL 1: ANKLE ALPHABET BALANCE (SUNDAY’S FEATURED DRILL) The eyes-closed progression is the critical advancement: when the eyes are closed, the brain cannot use visual information to correct postural sway. It must rely entirely on the ankle and hip proprioceptors and the vestibular system. This is the most specific training available for the sensory systems that actually prevent falls in real environments, where there is rarely time to look down at the feet before a misstep occurs. Progression: after the eyes-closed alphabet is manageable, add slow head turns during the balance. Turn the head slowly left and right while maintaining single-leg balance. This adds the vestibular challenge of gaze change to the proprioceptive challenge of single-leg stance.

DRILL 2: HEAD MOVEMENT BALANCE TRAINING Best for:  Specifically training the vestibular-ocular reflex and the brain’s ability to maintain balance during head movement — the scenario most commonly associated with falls during turning and head-turning movements. How to do it: Stand in a comfortable stance near a wall, feet shoulder-width apart Slowly turn the head to the right and hold 3 seconds, then to the left and hold 3 seconds — 10 repetitions each direction Then tilt the head back to look at the ceiling and hold 3 seconds, then down to look at the floor — 10 repetitions Progress: perform in tandem stance (heel to toe) during the head movements Further progress: perform with eyes closed during the head movements The inner ear (vestibular system) is most challenged by head movements, particularly in combination with postural demands. This drill specifically trains the vestibulo-spinal reflex — the automatic postural adjustment that the body makes in response to head movement — which becomes slower and less accurate after 60.

This exercise trains the vestibulo-ocular reflex — the coordination between vestibular signals and eye movement that allows the visual field to remain stable during head movement. Degradation of this reflex is a primary contributor to the ‘wobbly world’ feeling that many adults over 60 experience in busy visual environments.   Fix a small target (a dot on a piece of paper taped to a wall) at eye level about 2 to 3 feet away While keeping the eyes fixed on the target, slowly turn the head to the right and then left — the head moves but the eyes stay on the target Perform at increasing speeds: slow (2 seconds per rotation), medium (1 second), and then quickly (0.5 seconds) 20 repetitions each direction, 2 to 3 rounds If dizziness occurs, slow the head movement speed and gradually build tolerance over days to weeks How to do it:   Best for:  People who experience dizziness during head movement, who struggle with balance in visually busy environments (crowds, stores, traffic), or who feel unstable when quickly changing visual targets. DRILL 3: GAZE STABILIZATION EXERCISE

Many Medications Tied to Slower Daily Living Recovery After Stroke Rehabilitation

 Have your competent? doctor explain this to you. You want 100% RECOVERY, so ask your incompetent? doctor how EXACTLY you are going to get there! Not answering that correctly is a fireable offense.

Did your doctor somehow miss the recovery protocol that Pedro Bach-y-Rita used to recover fully back in 1958 with only a partial brain?

Many Medications Tied to Slower Daily Living Recovery After Stroke Rehabilitation

Older patients recovering from stroke and other cerebrovascular events who took six or more medications did not end their rehabilitation with less total functional improvement than patients on fewer drugs, according to a large observational study drawing on Japanese real-world claims data. Yet the pace of that recovery told a different story: patients whose medication burden persisted, grew, or was resolved during hospitalization all improved more slowly on a standard measure of daily living ability than those who stayed below the polypharmacy threshold throughout their stay.

The data came from the Japan Medical Data Center claims database, which contains anonymized inpatient medical and pharmacy claims from multiple healthcare institutions across Japan covering the period from 1 April 2014 to 31 January 2025. Patients who died during hospitalization, stayed 14 days or less, received anticancer agents, or lacked Functional Independence Measure (FIM) data at admission or discharge were excluded.

Polypharmacy was defined under Japan’s national health insurance system as the use of six or more medications, a threshold that also triggers a reimbursement incentive encouraging deprescribing during hospitalization. When counting drugs, the researchers excluded as-needed medications and topical agents such as ointments, but counted topical medications intended for systemic effects and used daily, such as isosorbide dinitrate patches. Combination drugs were counted as a single medication. Medication use at admission was based on drugs patients brought with them or prescriptions filled within seven days of admission, while discharge medication use was based on prescriptions written on the discharge date itself.

By comparing medication counts at admission and discharge, the team sorted patients into four groups. Nearly half of the cohort, 48.9 percent, had persistent polypharmacy, meaning six or more drugs at both admission and discharge. Another 14.8 percent developed incident polypharmacy during their stay, 8.8 percent achieved resolution of polypharmacy, and 27.6 percent remained below the threshold throughout hospitalization. Roughly 20 percent of all patients had hyper-polypharmacy, defined as ten or more medications, at both admission and discharge. The mean age of the cohort was 79 years, 96.3 percent were treated in non-public hospitals, and 57.3 percent were admitted to hospitals with fewer than 200 beds.

The primary outcome was FIM gain, the difference between FIM scores at discharge and admission. The FIM is an 18-item scale covering motor and cognitive domains including self-care, sphincter control, transfers, locomotion, communication, and social cognition, with total scores ranging from 18 to 126 points. The secondary outcomes were FIM efficiency, calculated as FIM gain divided by length of hospital stay, and length of stay itself. After multivariable linear regression adjusting for age, sex, body mass index, admission FIM score, smoking status, primary diagnosis, total hospital bed capacity, comorbidities such as hypertension, diabetes, dyslipidemia, heart failure, dementia, chronic kidney disease, and Parkinson’s disease, and admission period, polypharmacy status showed no significant association with FIM gain in either crude or adjusted models.

FIM efficiency, by contrast, was significantly lower in all three polypharmacy groups compared with the persistent non-polypharmacy group. The strongest negative association appeared in the incident polypharmacy group, with an adjusted coefficient of B = −0.114 and p < 0.001 in the model that also adjusted for persistent anticholinergic drug use, followed by the persistent polypharmacy group at B = −0.069. These associations held in sensitivity analyses stratified by pre- and post-2020 admission periods, and when polypharmacy was redefined by counting fixed-dose combination products according to their number of active ingredients, which reclassified only 1.6 percent of patients. Persistent anticholinergic drug use, defined as use recorded at both admission and discharge, was independently associated with lower FIM efficiency but not with FIM gain.

Length of hospital stay emerged as a critical piece of the puzzle. All three polypharmacy groups stayed significantly longer than the persistent non-polypharmacy group, with the largest adjusted difference in the incident polypharmacy group at 16.478 days, followed by 9.539 days for the persistent polypharmacy group and 9.533 days for the polypharmacy-resolved group, all statistically significant. Because length of stay sits in the denominator of FIM efficiency, the authors caution that the slower recovery pace may partly reflect longer hospitalization rather than a genuinely smaller amount of functional improvement. Patients who recover slowly may simply remain hospitalized longer while still ultimately reaching comparable levels of independence in daily activities.

The composition of newly added medications also proved revealing. Supplementary analyses of prescribing patterns showed that in the incident polypharmacy group, prescriptions of antipsychotics rose by roughly 10 percentage points and hypnotics and sedatives, including benzodiazepine receptor agonists, by roughly 15 percentage points between admission and discharge. Such centrally acting drugs are known to cause sedation, cognitive impairment, impaired balance, and increased fall risk, which could interfere with rehabilitation. However, the authors note that these prescriptions may equally have responded to delirium, behavioral symptoms, insomnia, pain, or difficulty participating in therapy during the hospitalization itself. Meanwhile, increases in antithrombotic, antihypertensive, antidiabetic, and lipid-lowering medications may have represented appropriate treatment of newly identified conditions or secondary prevention rather than harmful burden.

A subgroup analysis restricted to patients who already had polypharmacy at admission found that resolving it was not significantly associated with either FIM gain or FIM efficiency after adjustment, with an estimate of 0.345 for FIM gain and 0.015 for FIM efficiency when comparing the resolved group with the persistent polypharmacy group as reference. This suggests that deprescribing itself was not clearly linked to poorer recovery, and that the lower efficiency seen in the resolved group in the main analysis may reflect baseline differences or unmeasured factors. The timing of medication reduction was not recorded, so resolution occurring shortly before discharge may simply have had too little time to influence outcomes. The authors also point out that patients with polypharmacy at discharge had a higher prevalence of heart failure, a condition whose guideline-directed treatment often requires multiple drug classes, though the database lacked information on disease stage and severity.

The researchers emphasize several limitations. Detailed information on rehabilitation intensity and pharmacist-led medication optimization was unavailable, residual confounding and confounding by indication cannot be excluded because stroke severity and heart failure stage were not recorded, and patients without medication data at admission or discharge were excluded in ways that may have affected both the estimated prevalence of polypharmacy and the observed associations. Most fundamentally, because medication changes, functional outcomes, and length of stay were all assessed during the same hospitalization, the temporal direction of the associations cannot be established, and reverse causation remains possible. The authors conclude that polypharmacy status was not significantly associated with FIM gain, the primary outcome, but that all three polypharmacy groups showed lower FIM efficiency and longer hospital stays, and that these observational findings do not establish a causal relationship between changes in medication burden and functional recovery. They suggest that polypharmacy itself may nonetheless serve as a clinically meaningful marker of delayed functional recovery in post-acute rehabilitation, warranting attention to which drugs are being added and why.

Subject of Research: The association between polypharmacy and functional recovery in older patients undergoing cerebrovascular rehabilitation in Japan.

Article Title: Polypharmacy and Activities of Daily Living in Older Patients Undergoing Cerebrovascular Rehabilitation: An Observational Study Using Japanese Real-World Data

Article References: Ogawa, Y., Horii, T., Sakoh, M., & Mihara, K. (2026). Polypharmacy and Activities of Daily Living in Older Patients Undergoing Cerebrovascular Rehabilitation: An Observational Study Using Japanese Real-World Data. Drugs – Real World Outcomes. https://doi.org/10.1007/s40801-026-00589-z

Image Credits: AI Generated

DOI: 10.1007/s40801-026-00589-z

Keywords: polypharmacy, cerebrovascular rehabilitation, activities of daily living, Functional Independence Measure, older adults, convalescent rehabilitation ward, FIM efficiency, length of hospital stay, anticholinergic drugs, deprescribing, Japanese claims database, observational study

News Source: Cassandra Pierce. (October 28, 2026). Many Medications Tied to Slower Daily Living Recovery After Stroke Rehabilitation. Scienmag.